Showing results (131-140 of 187) with videos related to

Sort By:
Pageof 19
International Journal of Hematology|December 14, 2011
Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapyShokichi Tsukamoto, Masahiro Takeuchi, Chika Kawajiri, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2014
Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: a randomised phase III trial (TCOG GI-0801/BIRIP trial)Katsuhiko Higuchi, Satoshi Tanabe, Ken Shimada, et al.
Targeted Oncology|October 25, 2017
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal CancerYu Sunakawa, Akihito Tsuji, Tadamichi Denda, et al.
Molecular & Cellular Proteomics : MCP|March 24, 2012
Interleukin enhancer-binding factor 3/NF110 is a target of YM155, a suppressant of survivinNaoto Nakamura, Tomohiro Yamauchi, Masashi Hiramoto, et al.
The Lancet. Oncology|February 20, 2008
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialWasaburo Koizumi, Hiroyuki Narahara, Takuo Hara, et al.
Oncotarget|May 4, 2018
A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 2, 2014
Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide surveyNobuhisa Akamatsu, Yasuhiko Sugawara, Norihiro Kokudo, et al.
Experimental & Molecular Medicine|April 5, 2014
Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytesShokichi Tsukamoto, Masahiro Takeuchi, Takeharu Kawaguchi, et al.
Gynecologic Oncology|December 25, 2015
Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trialKenji Umayahara, Munetaka Takekuma, Yasuyuki Hirashima, et al.
Cancer Treatment and Research Communications|July 17, 2021
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibodyKenna Shirasuna, Gerald Koelsch, Cynthia Seidel-Dugan, et al.
Pageof 19